Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aldeyra Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ALDX
Nasdaq
2830
www.aldeyra.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aldeyra Therapeutics, Inc.
AbbVie's Atogepant Meets Goal in Late-Stage Menstrual Migraine Study
- Sep 11th, 2026 8:22 am
Bayer Secures FDA Nod for Sevabertinib's First-Line Use in NSCLC
- Sep 10th, 2026 10:05 am
Spyre's Anti-IL-23 Antibody Meets Goal in Ulcerative Colitis Study
- Sep 9th, 2026 7:56 am
Verastem Stock Skyrockets 121% in 3 Months: Here Is Why
- Sep 8th, 2026 8:09 am
CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally?
- Sep 7th, 2026 7:28 am
SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China
- Sep 4th, 2026 8:37 am
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
- Sep 3rd, 2026 9:49 am
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
- Sep 3rd, 2026 9:43 am
RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
- Sep 3rd, 2026 9:25 am
Here's Why You Should Add RNTX Stock to Your Portfolio Now
- Sep 3rd, 2026 9:01 am
AZN's Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal
- Sep 2nd, 2026 7:20 am
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
- Sep 1st, 2026 7:05 am
BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down
- Aug 31st, 2026 10:32 am
LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes
- Aug 31st, 2026 8:03 am
Here's Why You Should Add ARQT Stock to Your Portfolio Now
- Aug 28th, 2026 8:58 am
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
- Aug 28th, 2026 8:41 am
Levicept Appoints Darlene Deptula-Hicks as CFO
- Jul 7th, 2026 2:00 am
CEO, President & Director of Aldeyra Therapeutics Picks Up 18% More Stock
- Jun 10th, 2026 4:51 am
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors
- Jun 9th, 2026 6:30 pm
Scroll